Shanghai Kaibao Pharmaceutical CO.,Ltd reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 1,099.29 million compared to CNY 907.1 million a year ago. Revenue was CNY 1,100.58 million compared to CNY 908.01 million a year ago. Net income was CNY 140.11 million compared to CNY 106.12 million a year ago. Basic earnings per share from continuing operations was CNY 0.134 compared to CNY 0.1015 a year ago. Diluted earnings per share from continuing operations was CNY 0.134 compared to CNY 0.1015 a year ago.